Adoptive Cell Therapy for Metastatic Cancer

P

Peter Attia MD hosts a discussion with Steve Rosenberg.

ImmunityMedical

Quotes From Source

“We know the receptors, it's almost an engineering problem.”

Story of claim

Adoptive cell therapy involves engineering lymphocytes to target and potentially cure metastatic cancers by modifying receptor sequences like p53.

  • Goal: To engineer lymphocytes to target and cure metastatic cancers.
  • Proof: Engineering lymphocytes with known receptor sequences allows targeting and regression of metastatic cancers.
  • Nuances:
    • Genetic modification of lymphocytes to target cancer
    • Libraries of receptors against p53, kras isolated
  • Impact on Life: Potential for curing metastatic cancers, though requiring significant medical intervention and monitoring.

Investments

  • Price: Estimated $150,000 per treatment
  • Time: Extensive, involves multiple hospital visits
  • Effort: High effort due to complexity and ongoing medical care

Risks

Genetic modifications may lead to unforeseen immune reactions; requires extensive monitoring.

Alternatives

  • Targeted drug therapies
  • Experimental trials

Get Started 🚀

  • Discuss adoptive cell therapy with a cancer specialist
  • Evaluate eligibility based on cancer type and stage
  • Understand genetic modification implications

Brogevity AI can make mistakes. Check important info.

Reference Video